This guide deconstructs the pathophysiology of UTIs, exploring the anatomical risks in women, and the efficacy of antibiotic ...

The first new antibiotic for UTIs in nearly 30 years has been approved by regulators. Gepotidacin, also known as Blujepa, is ...

New study reveals that bacteria can survive antibiotic treatment through two fundamentally different "shutdown modes," not ...

Prior to the discovery of antibiotics, infectious diseases were rampant. Communicable diseases were the most common cause of death, and the average lifespan was about 47 years old. However, this ...

Pivmecillinam has been used for decades in Europe and may work for UTIs that don’t respond to other antibiotics. Urinary tract infections are one of the most common reasons for antibiotic use.

All of this disproportionately affects the elderly. In a 2023 study of patients with a median age of 75, approximately 30% of ...

Penicillin was the world's first antibiotic, a type of medication that kills or slows the growth of bacteria. After Scottish doctor Alexander Fleming discovered penicillin in a petri dish containing ...

Every winter, use of antibiotics surges as the public battle’s colds, coughs and other bugs. But are antibiotics always ...

In this special report, leading cardiac surgeon Dr. Devi Shetty discusses the escalating crisis of antibiotic resistance in ...

The bacteria behind the sexually transmitted disease gonorrhea is known for developing antibiotic resistance. Now there are two new treatment options.

Antibiotic-resistant infections have increased in England compared with pre-pandemic levels. There were 66,730 severe antibiotic-resistant infections last year, up 7% on 2019, according to data ...